FXAIX
Price
$266.59
Change
+$2.29 (+0.87%)
Updated
Sep 11 closing price
Net Assets
859.16B
PAXLX
Price
$11.39
Change
+$0.01 (+0.09%)
Updated
Sep 11 closing price
Net Assets
365.68M
Interact to see
Advertisement

FXAIX vs PAXLX

FXAIX vs PAXLX Comparison Chart in %
View a ticker or compare two or three
VS
FXAIX vs. PAXLX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FXAIX is a Buy and PAXLX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FXAIX has more cash in the bank: 859B vs. PAXLX (366M). FXAIX pays higher dividends than PAXLX: FXAIX (1.03) vs PAXLX (0.31). FXAIX was incepted earlier than PAXLX: FXAIX (15 years) vs PAXLX (10 years). PAXLX (0.98) is less costly to investors than FXAIX (0.01). PAXLX is a more actively managed with annual turnover of: 60.00 vs. FXAIX (3.00). FXAIX has a lower initial minimum investment than PAXLX: FXAIX (0) vs PAXLX (1000). FXAIX annual gain was more profitable for investors over the last year : 16.58 vs. PAXLX (-19.17). FXAIX return over 5 years is better than : 82.76 vs. PAXLX (-20.65).
FXAIXPAXLXFXAIX / PAXLX
Total Expense Ratio0.010.982%
Annual Report Gross Expense Ratio0.010.982%
Fund Existence15 years10 years-
Gain YTD11.7903.783312%
Front LoadN/AN/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets859B366M234,699%
Annual Yield % from dividends1.030.31334%
Returns for 1 year16.58-19.17-86%
Returns for 3 years76.90-8.40-916%
Returns for 5 years82.76-20.65-401%
Returns for 10 years294.63N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GENB15.720.33
+2.14%
Generate Biomedicines Inc
EURKU11.76N/A
N/A
Eureka Acquisition Corp.
AVTR14.81-0.07
-0.47%
Avantor
PRE23.47-0.19
-0.80%
Prenetics Global Limited
SER2.22-0.28
-11.20%
Serina Therapeutics